MedTrace Logo

Motor Parameters in Patients With Limb Girdle Muscular Dystrophy

NCT04772027 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2023-09-06

No results posted yet for this study

Summary

The primary objective of the study is to perform 2-year follow up with motor parameters evolution using instrumental assessments in patients with limb girdle muscular dystrophie, and to identify which motor parameters are sensitive to change.

The secondary objectives of the study are:

* to describe the changes of the parameters obtained from instrumental evaluations in comparison with the changes obtained from clinical assessments.
* to characterize the muscular impairments, the biomechanical gait disorders, the standing postural control disorders, the biomechanical upper limb disorders in spatial exploration, the limitation of upper limb capacities, the fatigue, the endurance, the patients' participation to their activities and their quality of life, in comparison with a healthy paired population.
* to highlight the relationships between muscular assessment parameters, biomechanical gait parameters, standing posture control and upper limb spatial exploration.
* to highlight the relationships between data from instrumental assessments and data from clinical assessments.
* to highlight the relationships between instrumental assessments data and clinical assessments data on one side, and features of patients (age, sex, duration since diagnosis, type of LGMD, rehabilitation in follow-up, sportive practices...) on the other side.

Conditions

  • Limb Girdle Muscular Dystrophies

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Céline BONNYAUD, PhD · Laboratoire d'analyse du mouvement, Service d'explorations fonctionnelles, Hôpital Raymond Poincaré, APHP

  • Samuel POUPLIN · Plateforme Nouvelles Technologies, Hôpital Raymond Poincaré, APHP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2025-01-31
Completion
2025-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04772027 on ClinicalTrials.gov